Epilepsy due to a MED25 Homozygous Pathogenic Founder Variant
Journal of Child Neurology · 2025
DOI: 10.1177/08830738251377579 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Child Neurology, 2025. Verfasst von Andy Cheuk-Him Ng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Alberta Children's Hospital Research Institute, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgar…. Hauptthemen laut MEDLINE: Epilepsy, Mediator Complex, Intellectual Disability. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Alberta Children's Hospital Research Institute.
Abstract (Originalsprache)
Previous reports have described a spectrum of clinical phenotypes in patients with MED25 pathogenic variants. One specific phenotype is the Basel-Vanagaite-Smirin-Yosef syndrome, which is a rare, autosomal recessive disorder characterized by a wide range of symptoms including eye abnormalities, cardiac abnormalities, palatal abnormalities, intellectual disability, and epilepsy. Although epilepsy appears to be common, the electroclinical phenotypes of patients with Basel-Vanagaite-Smirin-Yosef syndrome have not been well described. Here, we report 3 Basel-Vanagaite-Smirin-Yosef syndrome patients from 2 families of Lebanese descent with a homozygous MED25 founder variant from Alberta Children's Hospital, Calgary, Alberta. We describe in detail electroclinical phenotypes in each of these 3 patients. These patients developed seizures with onset between 2 and 3 years of age, multifocal and generalized discharges, as well as photoparoxysmal responses on electroencephalogram. We review the relevance of these epilepsy findings in the context of other published reports of Basel-Vanagaite-Smirin-Yosef syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Alberta Children's Hospital Research Institute, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- Division of Neurology, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta and Stollery Children's Hospital, Edmonton, Alberta, Canada.
- Department of Medical Genetics, University of Calgary, Calgary, Canada.
ORCID-Profile: Andy Cheuk-Him Ng
Förderung
- Alberta Children's Hospital Research Institute
Zitieren
APA
Ng, A. C., D'Alfonso, S., Innes, A. M., & Scantlebury, M. H. (2025). Epilepsy due to a MED25 Homozygous Pathogenic Founder Variant. Journal of Child Neurology. https://doi.org/10.1177/08830738251377579
Vancouver
Ng AC, D'Alfonso S, Innes AM, Scantlebury MH. Epilepsy due to a MED25 Homozygous Pathogenic Founder Variant. Journal of Child Neurology. 2025. doi:10.1177/08830738251377579
BibTeX
@article{Ng2025,
author = {Ng, Andy Cheuk-Him and D'Alfonso, Sabrina and Innes, A Micheil and Scantlebury, Morris H},
title = {Epilepsy due to a MED25 Homozygous Pathogenic Founder Variant},
journal = {Journal of Child Neurology},
year = {2025},
doi = {10.1177/08830738251377579}
}
EUVIMED